NCT01369433 2020-09-01A Rollover Protocol to Allow Continued Access to Tivozanib (AV 951) for Subjects Enrolled in Other Tivozanib ProtocolsAVEO Pharmaceuticals, Inc.Phase NA Terminated225 enrolled 7 charts
NCT00798889 2013-01-21Rollover Protocol for Prior SU011248 ProtocolsPfizerPhase NA Completed314 enrolled 6 charts